Medications for Prostate Issues
For benign prostatic hyperplasia (BPH), alpha-blockers (tamsulosin, alfuzosin, doxazosin, silodosin, terazosin) and 5-alpha reductase inhibitors (finasteride, dutasteride) are the primary medications, with combination therapy recommended for men with enlarged prostates to reduce disease progression and prevent complications. 1
Benign Prostatic Hyperplasia (BPH) Medications
Alpha-Blockers
- Alpha-blockers are first-line therapy for moderate to severe LUTS/BPH, providing rapid symptom relief by relaxing prostatic smooth muscle and relieving bladder outlet obstruction 1
- Available options include alfuzosin, doxazosin, silodosin, tamsulosin, and terazosin, all with similar clinical effectiveness but different side effect profiles 1
- These medications typically improve AUA Symptom Index scores by 4-7 points compared to 2-4 points with placebo 1
- Side effects include orthostatic hypotension, dizziness, fatigue, ejaculatory problems, and nasal congestion 1
- Tamsulosin has lower risk of orthostatic hypotension but higher risk of ejaculatory dysfunction compared to other alpha blockers 1
- Alpha-blockers can cause Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery; patients should inform their ophthalmologist before surgery 1, 2
5-Alpha Reductase Inhibitors (5-ARIs)
- 5-ARIs (finasteride, dutasteride) are indicated for men with prostatic enlargement (>30cc volume, PSA >1.5ng/mL, or palpable enlargement on DRE) 1, 3
- These medications reduce prostate size by inhibiting conversion of testosterone to dihydrotestosterone 1
- Finasteride is indicated to improve symptoms, reduce risk of acute urinary retention, and reduce need for surgery including TURP 3
- 5-ARIs take 3-6 months to show full effect, unlike alpha-blockers which work more quickly 1
- Common side effects include sexual dysfunction, including decreased libido, erectile dysfunction, and ejaculatory disorders 3
Combination Therapy
- Combination of alpha-blocker and 5-ARI is recommended for patients with enlarged prostates to prevent disease progression and reduce risks of urinary retention and future prostate surgery 1, 3
- The combination of finasteride with doxazosin is FDA-approved to reduce risk of symptomatic progression of BPH 3
- Combination therapy is more effective than either medication alone for preventing clinical progression in men with larger prostates 1
- Side effects of combination therapy are cumulative from both medication classes 3
PDE5 Inhibitors
- Tadalafil (5mg daily) can be used for men with LUTS/BPH, especially those with concurrent erectile dysfunction 1
- Sildenafil has also shown efficacy in improving LUTS/BPH symptoms, particularly nocturia when dosed at 50mg at night 4
- Combination of tadalafil with alpha blockers is not recommended as it offers no advantage over either agent alone 1
Other Medication Options
- Anticholinergics may be used alone or with alpha blockers for patients with predominant storage symptoms 1
- Beta-3-agonists in combination with alpha blockers may be offered to patients with moderate to severe predominant storage LUTS 1
Prostate Cancer Medications
- Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced or metastatic prostate cancer 5
- ADT options include:
- LHRH agonists (leuprolide, goserelin)
- LHRH antagonists (degarelix)
- Anti-androgens (bicalutamide, enzalutamide, apalutamide)
- Newer hormonal agents for castration-resistant prostate cancer include abiraterone acetate 5
- Chemotherapy (docetaxel, cabazitaxel) is used for metastatic disease 5
Prostatitis Medications
- Acute bacterial prostatitis is treated with antibiotics (fluoroquinolones, trimethoprim-sulfamethoxazole)
- Chronic bacterial prostatitis requires longer courses of antibiotics (4-6 weeks)
- Chronic prostatitis/chronic pelvic pain syndrome may be treated with alpha-blockers, anti-inflammatories, and muscle relaxants
Treatment Algorithm for BPH
- For mild symptoms: Watchful waiting with lifestyle modifications (reducing fluid intake at bedtime, decreasing caffeine and alcohol) 1
- For moderate to severe symptoms:
- Start with alpha-blocker (tamsulosin, alfuzosin, doxazosin, silodosin, or terazosin) 1
- For enlarged prostate (>30cc, PSA >1.5ng/mL): Add or use 5-ARI (finasteride or dutasteride) 1
- For storage symptoms: Consider adding anticholinergic or beta-3-agonist 1
- For concurrent erectile dysfunction: Consider PDE5 inhibitor (tadalafil 5mg daily) 1
Important Considerations and Pitfalls
- Alpha-blockers provide faster symptom relief (within weeks) while 5-ARIs take 3-6 months for full effect 1
- 5-ARIs reduce PSA levels by approximately 50%; PSA values should be doubled for cancer screening purposes 3
- Patients on alpha-blockers should be monitored for orthostatic hypotension, especially when initiating therapy 2
- Combination therapy has more side effects than monotherapy but provides better long-term outcomes in preventing disease progression 1
- PDE5 inhibitors should not be used with nitrates due to risk of severe hypotension 2